Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Medical Science Monitor

Volumn 17, Issue 4, 2011, Pages 11-15

  Maes, Michael ^a   Kubera, Marta ^b   Uytterhoeven, Marc ^c   Vrydags, Nicolas ^c   Bosmans, Eugene ^c  

^a Piyavate Hospital   (Thailand)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c AML Laboratory   (Belgium)

Author keywords

Antioxidantsas a marker of oxidative stress; CFS; Chronic fatigue syndrome; Inflammation; Myalgic encephalomyelitis; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMA PEROXIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF COVARIANCE; ANALYSIS OF VARIANCE; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC FATIGUE SYNDROME; CLINICAL ASSESSMENT; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NITROSATIVE STRESS; OXIDATIVE STRESS; RATING SCALE;

EID: 79953744583     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881699     Document Type: Article

References (40)

1. Maes M, Mihaylova I, Bosmans E: Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol Lett, 2007; 28: 456-62
2. Maes M, Mihaylova I, Kubera M, Bosmans E: Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol Lett, 2007; 28(4): 463-69
3. Maes M: Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatry, 2009; 22: 75-83
4. Maes M, Twisk FN: Chronic fatigue syndrome: Harvey and Wessely's (bio) psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine, 2010; 8: 35
5. Fletcher MA, Zeng XR, Barnes Z et al: Plasma cytokines in women with chronic fatigue syndrome. J Transl Med, 2009; 7: 96
6. Klimas NG, Salvato FR, Morgan R, Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol, 1990; 28(6): 1403-10
7. Maher KJ, Klimas NG, Fletcher MA: Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol, 2005; 142(3): 505-11
8. Mihaylova I, DeRuyter M, Rummens JL et al: Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett, 2007; 28(4): 477-83
9. Nijs J, De Meirleir K: Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo, 2005; 19(6): 1013-21
10. Myhill S, Booth NE, McLaren-Howard J: Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med, 2009; 2(1): 1-16
11. Behan WM, More IA, Behan PO: Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol, 1991; 83(1): 61-65
12. Gow JW, Hagan S, Herzyk P et al: A gene signature for post-infectious chronic fatigue syndrome. BMC Medicine Genomics, 2009, 2: 38
13. Kerr JR, Petty R, Burke B et al: Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis, 2008; 197(8): 1171-84
14. Vecchiet J, Cipollone F, Falasca K et al: Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett, 2003; 335: 151-54
15. Kennedy G, Spence VA, McLaren M et al: Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radicals in Biological Medicine, 2005; 39: 584-89
16. Jammes Y, Steinberg JG, Mambrini O et al: Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med, 2005; 257: 299-310
17. Smirnova IV, Pall ML: Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol Cell Biochem, 2003; 248: 93-95
18. Maes M, Mihaylova I, Kubera M et al: Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett, 2009; 30: 715-22
19. Tanaka M, Kovalenko SA, Gong JS et al: Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases. Ann NY Acad Sci, 1996; 786: 102-11
20. Zhang C, Baumer A, Mackay IR et al: Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome. Hum Mol Genet, 1995; 4: 751-54
21. Hokama Y, Campora CE, Hara C et al: Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome. J Clin Lab Anal, 2009; 23: 210-12
22. Vernon SD, Whistler T, Cameron B et al: Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infectious Diseases, 2006; 31: 6-15
23. Behan WM, More IA, Behan PO: Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol, 1991; 83(1): 61-65
24. Ohmori H, Kanayama N: Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev, 2005; 4: 224-29
25. Maes M, Mihaylova I, Leunis JC: Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett, 2006; 27: 615-21
26. Maes M, Mihaylova I, Leunis JC: Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett, 2007; 28: 861-67
27. Maes M, Mihaylova I, Kubera M, Leunis JC: An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Neuro Endocrinol Lett, 2008; 29: 313-19
28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). American Psychiatric Association, Washington, D.C., 2000
29. Fukuda K, Straus SE, Hickie I et al: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med, 1994; 121: 953-59
30. Zachrisson O, Regland B, Jahreskog M et al: A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res, 2002; 52: 501-9
31. Maes M, Mihaylova I, Kubera M et al: Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett, 2009; 30: 462-69
32. Maes M, Mihaylova I, De Ruyter M: Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. Neuro Endocrinol Lett, 2005; 26: 487-92
33. Maes M, Mihaylova I, De Ruyter M: Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord, 2006; 90: 141-47
34. Miwa K, Fujita M: Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int J Cardiol, 2009; 136(2): 238-39
35. Singal A, Kaur S, Tirkey N, Chopra K: Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food, 2005; 8: 47-52
36. Singh A, Naidu PS, Gupta S, Kulkarni SK: Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food, 2002; 5: 211-20
37. Singh A, Garg V, Gupta S, Kulkarni SK: Role of antioxidants in chronic fatigue syndrome in mice. Indian Journal of Experimental Biology, 2002; 40: 1240-44
38. Sachdeva AK, Kuhad A, Tiwari V, Chopra K: Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behavior and Brain Research, 2009; 205: 414-20
39. Maes M: An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry, 2010 Jul 4. [Epub ahead of print] PubMed PMID: 20609377
40. Maes M, Mihaylova I, Kubera M et al: Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord, 2010; 125(1-3): 287-94. Epub 2010 Jan 18. PubMed PMID: 20083310